Pain management can be an essential element of patient care. However Federal charges against a Texas doctor announced this week remind physician and other prescribers warn of the perils of overprescribing and other breaches of legal and ethical standards when prescribing opiates or other controlled substances.
An indictment unsealed April 2, 2026, in the Southern District of Texas charges Weslaco, Texas doctor James Robles with operating a cash-only clinic in Houston that he illegally used to sell prescriptions for controlled substances.
According to court documents, Robles, a medical doctor licensed to practice in Texas, conspired with others to illegally prescribe oxycodone, hydrocodone and carisoprodol – all controlled substances with substantial street value that were in high demand on Houston’s black market.
Operating from his cash-only Houston clinic, the Justice Department Robles allegedly deposited more than $2 million in cash into bank accounts controlled by Robles for prescribing approximately 2.9 million pills of hydrocodone, 1.3 million pills of oxycodone and 1.1 million pills of carisoprodol in just over four years.
According to the indictment, Robles allegedly often did not see or examine his purported patients before prescribing them opioids and other controlled substances.
The Justice Department charges Robles allegedly sold prescriptions to “crew leaders” who recruited others to pose as patients, filled Robles’ prescriptions at complicit pharmacies and resold the drugs on the black market.
Robles is charged with one count of conspiracy to distribute and dispense controlled substances, one count of distributing and dispensing controlled substances and one count of maintaining a drug involved premises. If convicted, he faces a maximum penalty of 20 years in prison on each count.
The Drug Enforcement Administration (DEA) is investigating the case, which the Justice Department Criminal Division’s Fraud Section is prosecuting.
The Fraud Section leads the Criminal Division’s efforts to combat health care fraud through the Health Care Fraud Strike Force Program, including those targeting physicians and others suspected of running “pill mills” or other illegal distribution of opioids or other controlled substances.
An “opiate pill mill” typically refers to a clinic or office associated with high-volume, improper prescribing of opioid medications. Red flags that often can trigger scrutiny for potential illegal pill mill activity generally include but are not limited to:
- Prescribers frequently writing scripts for opiates, or other controlled substances that deviate from guidelines typical within the overall prescribing population such as to a high volume of patients, in quantities or for durations that exceed thuudelineor with a frequency that exceeds the frequencies compared to the healthcare community as a whole;
- Overcrowded waiting rooms with patients seeking prescriptions;
- Providers rapidly writing prescriptions with minimal examination;
- Large quantities of opioidor other controlled substance scripts, pill bottles or prescription pads; or
- High-volume dispensing environments.
Although most legitimate prescribers do not prescribe a sufficient quantity of opiates or other controlled substances, certain practices may in the course of their legitimate treatment of patients engage in prescribing practices that could trigger pill mills scrutiny. Examples include where a patient chronic condition or recovery involves a longer period of opiate or other controlled substance management, such as orthopedic or other surgeries with long-term, painful recoveries; chronic pain patients; oncology, cardiology, or other similar conditions involving ongoing or frequent; or substance abuse or other addiction, treatment.
It also is important to keep in mind that pill mill scrutiny is not limited to opioid and other pain management treatment. It also extends to other controlled substance prescribing patterns, where the medication’s are commonly subject to abuse such as the prescription of controlled substances for certain mental health disorders, attention deficit disorder, or other treatments involving the use of controlled substances commonly subject to abuse.
Providers prescribing controlled substances to use care to familiarize themselves with applicable guidelines for scrutiny, such as those adopted at the federal or state level. Provider should keep in mind that these guidelines do not necessarily take into account practice specific research or guidelines for the management of pain or other conditions common in their practice as compared to those by other practices, not involving those circumstances.
In all cases providers should previously adhere to documentation and medical charting to demonstrate the justification for their prescription.
Providers also should adopt carefully crafted policies for patient management of the use of these prescriptions that include appropriate systems were monitoring for potential abuse, management of flags for abuse, impossible termination of the patient relationship in accordance with ethical practices if necessary.
Providers also should recognize that many of the investigations involving pill mill or other controlled substance prescribing abuse arise from reports or complaints made by pharmacies or other third parties. Particularly since recent settlements involving pharmacies, pharmacist and pharmacies in increasingly report suspected misconduct to licensing boards or rather authorities where they believe the frequency may be high to protect themselves from liability.
Since March 2007, the Task Force working through its eight strike forces across the country, has charged more than 6,200 defendants who collectively billed federal health care programs and private insurers more than $45 billion. In addition, the Centers for Medicare & Medicaid Services, working in conjunction with the Office of the Inspector General for the Department of Health and Human Services, are taking steps to hold providers accountable for their involvement in health care fraud schemes.
If you have questions about this or other health care concerns, contact the author.
For More Information
We hope this update is helpful. For more information about the or other health or other employee benefits, human resources, or health care developments, please contact the author Cynthia Marcotte Stamer via e-mail or via telephone at (214) 452 -8297.
Solutions Law Press, Inc. invites you receive future updates by registering on our Solutions Law Press, Inc. Website and participating and contributing to the discussions in our Solutions Law Press, Inc. LinkedIn SLP Health Care Risk Management & Operations Group, HR & Benefits Update Compliance Group, and/or Coalition for Responsible Health Care Policy.
About the Author
Peer recognized as “Top Rated Lawyer” and “LEGAL LEADER™ “Top Rated Lawyer” and “Best Lawyer” for her work in Health Care Law, Labor and Employment Law; ERISA & Employee Benefits,” and “Business and Commercial Law,” Cynthia Marcotte Stamer is an A Martindale-Hubble “AV-Preeminent” (Top 1%) attorneys board certified in labor and employment law by the Texas Board of Legal Specialization and management consultant, author, public policy advocate and lecturer widely known for her more than 35 years of health industry and other management work, public policy leadership and advocacy, coaching, teachings, and publications including leading edge work on PBM, pharmacy and pharmaceutical and other health care, managed care, insurance, and insured and self-insured contracting, design, administration and regulation..
Author of numerous highly regarded works on PBM and other health plan contracting and design, Immediate Past Chair of the ABA International Section Life Sciences Committee and the Tort Trial and Insurance Practice Section Medicine and Law Committee, past Chair of the ABA Health Law Section Managed Care & Insurance Interest Group and past Group Chair and current Welfare Benefit Committee Co-Chair of the ABA RPTE Employee Benefits & Other Compensation Group, Ms. Stamer is most widely recognized for her decades of pragmatic, leading edge work, scholarship and thought leadership on health and other privacy and data security and other health industry legal, public policy and operational concerns.
Ms. Stamer’s work throughout her career has focused heavily on working with health care and managed care, health and other employee benefit plan, insurance and financial services and other public and private organizations and their technology, data, and other service providers and advisors domestically and internationally with legal and operational compliance and risk management, performance and workforce management, regulatory and public policy and other legal and operational concerns. As a part of this work, she has continuously and extensively worked with domestic and international health plans, their sponsors, fiduciaries, administrators, and insurers; managed care and insurance organizations; third party administrators and other health benefit service providers; hospitals, health care systems and other health care providers, accreditation, peer review and quality committees and organizations; billing, utilization management, management services organizations, group purchasing organizations; pharmaceutical, pharmacy, and prescription benefit management and organizations; consultants; investors; EMR, claims, payroll and other technology, billing and reimbursement and other services and product vendors; products and solutions consultants and developers; investors; managed care organizations, self-insured health and other employee benefit plans, their sponsors, fiduciaries, administrators and service providers, insurers and other payers, health industry advocacy and other service providers and groups and other health and managed care industry clients as well as federal and state legislative, regulatory, investigatory and enforcement bodies and agencies.
She also has extensive experience helping health care systems and organizations, group and individual health care providers, health plans and insurers, health IT, life sciences and other health industry clients prevent, investigate, manage and resolve sexual assault, abuse, harassment and other organizational, provider and employee misconduct and other performance and behavior; manage Section 1557, Civil Rights Act and other discrimination and accommodation, and other regulatory, contractual and other compliance; vendors and suppliers; contracting and other terms of participation, medical billing, reimbursement, claims administration and coordination, Medicare, Medicaid, CHIP, Medicare/Medicaid Advantage, ERISA and other payers and other provider-payer relations, contracting, compliance and enforcement; Form 990 and other nonprofit and tax-exemption; fundraising, investors, joint venture, and other business partners; quality and other performance measurement, management, discipline and reporting; physician and other workforce recruiting, performance management, peer review and other investigations and discipline, wage and hour, payroll, gain-sharing and other pay-for performance and other compensation, training, outsourcing and other human resources and workforce matters; board, medical staff and other governance; strategic planning, process and quality improvement; meaningful use, EMR, HIPAA and other technology, data security and breach and other health IT and data; STARK, ant kickback, insurance, and other fraud prevention, investigation, defense and enforcement; audits, investigations, and enforcement actions; trade secrets and other intellectual property; crisis preparedness and response; internal, government and third-party licensure, credentialing, accreditation, HCQIA and other peer review and quality reporting, audits, investigations, enforcement and defense; patient relations and care; internal controls and regulatory compliance; payer-provider, provider-provider, vendor, patient, governmental and community relations; facilities, practice, products and other sales, mergers, acquisitions and other business and commercial transactions; government procurement and contracting; grants; tax-exemption and not-for-profit; privacy and data security; training; risk and change management; regulatory affairs and public policy; process, product and service improvement, development and innovation, and other legal and operational compliance and risk management, government and regulatory affairs and operations concerns. to establish, administer and defend workforce and staffing, quality, and other compliance, risk management and operational practices, policies and actions; comply with requirements; investigate and respond to Board of Medicine, Health, Nursing, Pharmacy, Chiropractic, and other licensing agencies, Department of Aging & Disability, FDA, Drug Enforcement Agency, OCR Privacy and Civil Rights, Department of Labor, IRS, HHS, DOD, FTC, SEC, CDC and other public health, Department of Justice and state attorneys’ general and other federal and state agencies; JCHO and other accreditation and quality organizations; private litigation and other federal and state health care industry actions: regulatory and public policy advocacy; training and discipline; enforcement; and other strategic and operational concerns.
Author of a multitude of highly regarded publications and presentations, Ms. Stamer is widely recognized for her thought leadership on these and other health care, managed care and other health plan,and other health industry matters. In addition, Ms. Stamer contributes her time and leadership to numerous policy, professional, civil and other organizations including service as the, the American Bar Association (ABA) International Section Life Sciences Committee Vice Chair, a Scribe for the ABA Joint Committee on Employee Benefits (JCEB) Annual OCR Agency Meeting and a former Council Representative, Past Chair of the ABA Managed Care & Insurance Interest Group, former Vice President and Executive Director of the North Texas Health Care Compliance Professionals Association, past Board President of Richardson Development Center (now Warren Center) for Children Early Childhood Intervention Agency, past North Texas United Way Long Range Planning Committee Member, and past Board Member and Compliance Chair of the National Kidney Foundation of North Texas, and a Fellow in the American College of Employee Benefit Counsel, the American Bar Foundation and the Texas Bar Foundation, Ms. Stamer also shares her extensive publications and thought leadership as well as leadership involvement in a broad range of other professional and civic organizations. For more information about Ms. Stamer or her health industry and other experience and involvements, see www.cynthiastamer.com or contact Ms. Stamer via telephone at (214) 452-8297 or via e-mail here.
About Solutions Law Press, Inc.™
Solutions Law Press, Inc.™ provides human resources and employee benefit and other business risk management, legal compliance, management effectiveness and other coaching, tools and other resources, training and education on leadership, governance, human resources, employee benefits, data security and privacy, insurance, health care and other key compliance, risk management, internal controls and operational concerns. If you find this of interest, you also be interested reviewing some of our other Solutions Law Press, Inc.™ resources.
If you or someone else you know would like to receive future updates about developments on these and other concerns, please be sure that we have your current contact information including your preferred e-mail by creating your profile here.
NOTICE: These statements and materials are for general information and purposes only. They do not establish an attorney-client relationship, are not legal advice or an offer or commitment to provide legal advice, and do not serve as a substitute for legal advice. Readers are urged to engage competent legal counsel for consultation and representation considering the specific facts and circumstances presented in their unique circumstance at the particular time. No comment or statement in this publication is to be construed as legal advice or an admission. The author reserves the right to qualify or retract any of these statements at any time. Likewise, the content is not tailored to any particular situation and does not necessarily address all relevant issues. Because the law constantly and often rapidly evolves, subsequent developments that could impact the currency and completeness of this discussion are likely. The author and Solutions Law Press, Inc. disclaim and have no responsibility to provide any update or otherwise notify anyone of any fact or law specific nuance, change, limitation, or other condition that might affect the suitability of reliance upon these materials or information otherwise conveyed in connection with this program. Readers may not rely upon, are solely responsible for, and assume the risk and all liabilities resulting from their use of this publication.
Circular 230 Compliance. The following disclaimer is included to ensure that we comply with U.S. Treasury Department Regulations. Any statements contained herein are not intended or written by the writer to be used, and nothing contained herein can be used by you or any other person, for the purpose of (1) avoiding penalties that may be imposed under federal tax law, or (2) promoting, marketing or recommending to another party any tax-related transaction or matter addressed herein.
©2026 Cynthia Marcotte Stamer. Non-exclusive right to republish granted to Solutions Law Press, Inc.™ For information about republication, please contact the author directly. All other rights reserved.
Posted by Cynthia Marcotte Stamer 
slphealthcareupdate.com 